Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burger

Showing results (801-810 of 1,123) with videos related to

Pageof 113
Sort By:
Clinical Pharmacology and Therapeutics|February 2, 2002
The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteersRob E Aarnoutse, Karin J T Grintjes, Denise S C Telgt, et al.
Journal of Clinical Pathology|May 23, 2006
In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiologyM van Seters, F J W ten Kate, M van Beurden, et al.
Cancer|October 6, 2010
Prognostic model for survival in patients with early stage cervical cancerPetra Biewenga, Jacobus van der Velden, Ben Willem J Mol, et al.
Antiviral Therapy|May 12, 2004
Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected childrenPieter L A Fraaij, Jennifer Neubert, Alina S Bergshoeff, et al.
Pharmaceutics|May 27, 2023
Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic ModellingTom G Jacobs, Marika A de Hoop-Sommen, Thomas Nieuwenstein, et al.
The Lancet. Oncology|April 4, 2019
Dose recommendations for anticancer drugs in patients with renal or hepatic impairmentStefanie D Krens, Gerben Lassche, Frank G A Jansman, et al.
Cancer|November 19, 2002
Vulvar carcinoma. The price of less radical surgeryJoanne A De Hullu, Harry Hollema, Sietske Lolkema, et al.
Antiviral Therapy|March 19, 2013
Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional studyAlexander Zoufaly, Quirine Fillekes, Raffaela Hammerl, et al.
The Journal of Antimicrobial Chemotherapy|December 5, 2014
A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patientsR J M Brüggemann, W J F M Van Der Velden, C A J Knibbe, et al.
Gynecologic Oncology|September 11, 2009
Validation of existing prognostic models in patients with early-stage cervical cancerPetra Biewenga, Jacobus van der Velden, Ben Willem J Mol, et al.
Pageof 113

Showing results (801-810 of 1,123) with videos related to

Sort By:
Pageof 113
Clinical Pharmacology and Therapeutics|February 2, 2002
The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteersRob E Aarnoutse, Karin J T Grintjes, Denise S C Telgt, et al.
Journal of Clinical Pathology|May 23, 2006
In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiologyM van Seters, F J W ten Kate, M van Beurden, et al.
Cancer|October 6, 2010
Prognostic model for survival in patients with early stage cervical cancerPetra Biewenga, Jacobus van der Velden, Ben Willem J Mol, et al.
Antiviral Therapy|May 12, 2004
Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected childrenPieter L A Fraaij, Jennifer Neubert, Alina S Bergshoeff, et al.
Pharmaceutics|May 27, 2023
Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic ModellingTom G Jacobs, Marika A de Hoop-Sommen, Thomas Nieuwenstein, et al.
The Lancet. Oncology|April 4, 2019
Dose recommendations for anticancer drugs in patients with renal or hepatic impairmentStefanie D Krens, Gerben Lassche, Frank G A Jansman, et al.
Cancer|November 19, 2002
Vulvar carcinoma. The price of less radical surgeryJoanne A De Hullu, Harry Hollema, Sietske Lolkema, et al.
Antiviral Therapy|March 19, 2013
Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional studyAlexander Zoufaly, Quirine Fillekes, Raffaela Hammerl, et al.
The Journal of Antimicrobial Chemotherapy|December 5, 2014
A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patientsR J M Brüggemann, W J F M Van Der Velden, C A J Knibbe, et al.
Gynecologic Oncology|September 11, 2009
Validation of existing prognostic models in patients with early-stage cervical cancerPetra Biewenga, Jacobus van der Velden, Ben Willem J Mol, et al.
Pageof 113